Kathryn J. Collier - Jul 25, 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Jul 25, 2024
Transactions value $
$7,280
Form type
4
Date filed
7/29/2024, 04:18 PM
Previous filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Purchase $7.28K +4K +145.99% $1.82 6.74K Jul 25, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.